Inducible nitric oxide synthase mediates DNA double strand breaks in Human T-Cell Leukemia Virus Type 1-induced leukemia/lymphoma

Retrovirology

Volumn 12, Issue 1, 2015, Pages

  Baydoun, Hicham H ^a   Cherian, Mathew A ^a   Green, Patrick ^b   Ratner, Lee ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

ATLL; DNA damage; DSBs; HTLV 1; NF B; Nitric oxide; Tax

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; JANUS KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; STAT PROTEIN; TAX PROTEIN; AMIDINE; COUMARIN DERIVATIVE; N-(6-BROMO-7-HYDROXYCOUMARIN-4-YL)METHOXYCARBONYL-N-(3-(AMINOMETHYL)BENZYL)ACETAMIDE; NOS2 PROTEIN, HUMAN; TAX PROTEIN, HUMAN T-LYMPHOTROPHIC VIRUS 1;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA REPLICATION; DOUBLE STRANDED DNA BREAK; ENZYME ACTIVATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; HUMAN T-LYMPHOTROPIC VIRUS 1; LEUKEMOGENESIS; MACROPHAGE; NEUTROPHIL; PROTEIN EXPRESSION; PROTEIN INTERACTION; T CELL LEUKEMIA; T LYMPHOCYTE; T-CELL LEUKEMIA CELL LINE; ADULT; GENE EXPRESSION REGULATION; GENETICS; HTLV-1 INFECTION; JURKAT CELL LINE; METABOLISM; PATHOGENICITY; REGULATOR GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR CELL CULTURE; VIROLOGY;

HUMAN T-LYMPHOTROPIC VIRUS 1;

ADULT; AMIDINES; COUMARINS; DNA BREAKS, DOUBLE-STRANDED; GENE EXPRESSION REGULATION; GENE PRODUCTS, TAX; GENES, PX; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JANUS KINASES; JURKAT CELLS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TUMOR CELLS, CULTURED;

EID: 84938893582     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/s12977-015-0196-y     Document Type: Article

References (73)

1. Gessain A, Cassar O (2012) Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol 3:388
2. Iwanaga M, Watanabe T, Yamaguchi K (2012) Adult T-cell leukemia: a review of epidemiological evidence. Front Microbiol 3:322
3. Goncalves DU, Proietti FA, Ribas JG, Araujo MG, Pinheiro SR, Guedes AC et al (2010) Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev 23:577-589
4. Currer R, Van Duyne R, Jaworski E, Guendel I, Sampey G, Das R et al (2012) HTLV tax: a fascinating multifunctional co-regulator of viral and cellular pathways. Front Microbiol 3:406
5. Matsuoka M, Jeang KT (2011) Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene 30:1379-1389
6. Rauch DA, Ratner L (2011) Targeting HTLV-1 activation of NFkappaB in mouse models and ATLL patients. Viruses 3:886-900
7. Bellon M, Nicot C (2008) Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells. Blood 112:2946-2955
8. Giam CZ, Jeang KT (2007) HTLV-1 Tax and adult T-cell leukemia. Front Biosci 12:1496-1507
9. Ratner L (2011) JAK blockade and HTLV. Blood 117:1771-1772
10. Pancewicz J, Taylor JM, Datta A, Baydoun HH, Waldmann TA, Hermine O et al (2010) Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia. Proc Natl Acad Sci USA 107:16619-16624
11. Bellon M, Baydoun HH, Yao Y, Nicot C (2010) HTLV-I Tax-dependent and -independent events associated with immortalization of human primary T lymphocytes. Blood 115:2441-2448
12. Grossman WJ, Ratner L (1996) Transgenic mouse models for HTLV-I infection. J Acquir Immune Defic Syndr Hum Retrovirol 13(Suppl 1):S162-S169
13. Kfoury Y, Nasr R, Journo C, Mahieux R, Pique C, Bazarbachi A (2012) The multifaceted oncoprotein Tax: subcellular localization, posttranslational modifications, and NF-kappaB activation. Adv Cancer Res 113:85-120
14. Chevalier SA, Durand S, Dasgupta A, Radonovich M, Cimarelli A, Brady JN et al (2012) The transcription profile of Tax-3 is more similar to Tax-1 than Tax-2: insights into HTLV-3 potential leukemogenic properties. PLoS One 7:e41003
15. Pise-Masison CA, Radonovich M, Mahieux R, Chatterjee P, Whiteford C, Duvall J et al (2002) Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes. Cancer Res 62:3562-3571
16. Kroncke KD, Fehsel K, Kolb-Bachofen V (1998) Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 113:147-156
17. Mungrue IN, Husain M, Stewart DJ (2002) The role of NOS in heart failure: lessons from murine genetic models. Heart Fail Rev 7:407-422
18. Mungrue IN, Gros R, You X, Pirani A, Azad A, Csont T et al (2002) Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J Clin Invest 109:735-743
19. Chinje EC, Stratford IJ (1997) Role of nitric oxide in growth of solid tumours: a balancing act. Essays Biochem 32:61-72
20. Anttila MA, Voutilainen K, Merivalo S, Saarikoski S, Kosma VM (2007) Prognostic significance of iNOS in epithelial ovarian cancer. Gynecol Oncol 105:97-103
21. Harada K, Supriatno, Kawaguchi S, Tomitaro O, Yoshida H, Sato M (2004) Overexpression of iNOS gene suppresses the tumorigenicity and metastasis of oral cancer cells. In Vivo 18:449-455
22. Watanabe K, Kawamori T, Nakatsugi S, Wakabayashi K (2000) COX-2 and iNOS, good targets for chemoprevention of colon cancer. BioFactors 12:129-133
23. Gochman E, Mahajna J, Shenzer P, Dahan A, Blatt A, Elyakim R et al (2012) The expression of iNOS and nitrotyrosine in colitis and colon cancer in humans. Acta Histochem 114:827-835
24. McCarthy HO, Zholobenko AV, Wang Y, Canine B, Robson T, Hirst DG et al (2011) Evaluation of a multi-functional nanocarrier for targeted breast cancer iNOS gene therapy. Int J Pharm 405:196-202
25. Hiraku Y, Kawanishi S, Ichinose T, Murata M (2010) The role of iNOS-mediated DNA damage in infection- and asbestos-induced carcinogenesis. Ann N Y Acad Sci 1203:15-22
26. Baydoun HH, Bai XT, Shelton S, Nicot C (2012) HTLV-I tax increases genetic instability by inducing DNA double strand breaks during DNA replication and switching repair to NHEJ. PLoS One 7:e42226
27. Chaib-Mezrag H, Lemacon D, Fontaine H, Bellon M, Bai XT, Drac M et al (2014) Tax impairs DNA replication forks and increases DNA breaks in specific oncogenic genome regions. Mol Cancer 13:205
28. Kolodziejski PJ, Koo JS, Eissa NT (2004) Regulation of inducible nitric oxide synthase by rapid cellular turnover and cotranslational down-regulation by dimerization inhibitors. Proc Natl Acad Sci USA 101:18141-18146
29. Eissa NT, Haggerty CM, Palmer CD, Patton W, Moss J (2001) Identification of residues critical for enzymatic activity in the domain encoded by exons 8 and 9 of the human inducible nitric oxide synthase. Am J Respir Cell Mol Biol 24:616-620
30. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883-899
31. Yamagishi M, Nakano K, Miyake A, Yamochi T, Kagami Y, Tsutsumi A et al (2012) Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers. Cancer Cell 21:121-135
32. Sonoki T, Matsuzaki H, Nagasaki A, Hata H, Yoshida M, Matsuoka M et al (1999) Detection of inducible nitric oxide synthase (iNOS) mRNA by RT-PCR in ATL patients and HTLV-I infected cell lines: clinical features and apoptosis by NOS inhibitor. Leukemia 13:713-718
33. Mori N, Nunokawa Y, Yamada Y, Ikeda S, Tomonaga M, Yamamoto N et al (1999) Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells. Blood 94:2862-2870
34. Kolodziejska KE, Burns AR, Moore RH, Stenoien DL, Eissa NT (2005) Regulation of inducible nitric oxide synthase by aggresome formation. Proc Natl Acad Sci USA 102:4854-4859
35. Cucinotta FA, Pluth JM, Anderson JA, Harper JV, O'Neill P (2008) Biochemical kinetics model of DSB repair and induction of gamma-H2AX foci by non-homologous end joining. Radiat Res 169:214-222
36. Wu CY, Kang HY, Yang WL, Wu J, Jeong YS, Wang J et al (2011) Critical role of monoubiquitination of histone H2AX protein in histone H2AX phosphorylation and DNA damage response. J Biol Chem 286:30806-30815
37. Nagata K, Ohtani K, Nakamura M, Sugamura K (1989) Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line. Jurkat. J Virol 63:3220-3226
38. Kwon H, Ogle L, Benitez B, Bohuslav J, Montano M, Felsher DW et al (2005) Lethal cutaneous disease in transgenic mice conditionally expressing type I human T cell leukemia virus Tax. J Biol Chem 280:35713-35722
39. Lavorgna A, Matsuoka M, Harhaj EW (2014) A critical role for IL-17RB signaling in HTLV-1 tax-induced NF-kappaB activation and T-cell transformation. PLoS Pathog 10:e1004418
40. Dassouki Z, Sahin U, El Hajj H, Jollivet F, Kfoury Y, Lallemand-Breitenbach V et al (2015) ATL response to arsenic/interferon therapy is triggered by SUMO/PML/RNF4-dependent Tax degradation. Blood 125:474-482
41. Lowenstein CJ, Padalko E (2004) iNOS (NOS2) at a glance. J Cell Sci 117:2865-2867
42. Jianjun Y, Zhang R, Lu G, Shen Y, Peng L, Zhu C et al (2013) T cell-derived inducible nitric oxide synthase switches off Th17 cell differentiation. J Exp Med 210:1447-1462
43. Chaturvedi MM, Sung B, Yadav VR, Kannappan R, Aggarwal BB (2011) NF-kappaB addiction and its role in cancer: 'one size does not fit all'. Oncogene 30:1615-1630
44. Choudhari SK, Chaudhary M, Bagde S, Gadbail AR, Joshi V (2013) Nitric oxide and cancer: a review. World J Surg Oncol 11:118
45. Zhang J, Peng B (2009) NF-kappaB promotes iNOS and VEGF expression in salivary gland adenoid cystic carcinoma cells and enhances endothelial cell motility in vitro. Cell Prolif 42:150-161
46. Pautz A, Art J, Hahn S, Nowag S, Voss C, Kleinert H (2010) Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide Biol Chem 23:75-93
47. Guo Z, Shao L, Zheng L, Du Q, Li P, John B et al (2012) miRNA-939 regulates human inducible nitric oxide synthase posttranscriptional gene expression in human hepatocytes. Proc Natl Acad Sci USA 109:5826-5831
48. Higuchi M, Fujii M (2009) Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis. Retrovirology 6:117
49. Tschugguel W, Pustelnik T, Lass H, Mildner M, Weninger W, Schneeberger C et al (1999) Inducible nitric oxide synthase (iNOS) expression may predict distant metastasis in human melanoma. Br J Cancer 79:1609-1612
50. Charoenthongtrakul S, Zhou Q, Shembade N, Harhaj NS, Harhaj EW (2011) Human T cell leukemia virus type 1 Tax inhibits innate antiviral signaling via NF-kappaB-dependent induction of SOCS1. J Virol 85:6955-6962
51. Yasunaga J, Matsuoka M (2011) Molecular mechanisms of HTLV-1 infection and pathogenesis. Int J Hematol 94:435-442
52. Ratner L, Portis T, Robek M, Harding J, Grossman W (2000) Studies of the immortalizing activity of HTLV type 1 Tax, using an infectious molecular clone and transgenic mice. AIDS Res Hum Retroviruses 16:1647-1651
53. Portis T, Harding JC, Ratner L (2001) The contribution of NF-kappa B activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors. Blood 98:1200-1208
54. Edwards DC, Marriott SJ (2008) Human T-cell leukemia virus type 1 Tax relieves repression of proliferating cell nuclear antigen gene expression. J Virol 82:11714-11722
55. Suzuki T, Uchida-Toita M, Andoh T, Yoshida M (2000) HTLV-1 tax oncoprotein binds to DNA topoisomerase I and inhibits its catalytic activity. Virology 270:291-298
56. Ducu RI, Dayaram T, Marriott SJ (2011) The HTLV-1 Tax oncoprotein represses Ku80 gene expression. Virology 416:1-8
57. Jin DY, Spencer F, Jeang KT (1998) Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 93:81-91
58. Merling R, Chen C, Hong S, Zhang L, Liu M, Kuo YL et al (2007) HTLV-1 Tax mutants that do not induce G1 arrest are disabled in activating the anaphase promoting complex. Retrovirology 4:35
59. Kuo YL, Giam CZ (2006) Activation of the anaphase promoting complex by HTLV-1 tax leads to senescence. EMBO J 25:1741-1752
60. Liu B, Hong S, Tang Z, Yu H, Giam CZ (2005) HTLV-I Tax directly binds the Cdc20-associated anaphase-promoting complex and activates it ahead of schedule. Proc Natl Acad Sci USA 102:63-68
61. Samaan A, Mahana W (2007) Constitutive and induced activation of JAK/Stat pathway in leukemogenic and asymptomatic human T-cell lymphoptropic virus type 1 (HTLV-1) transformed rabbit cell lines. Immunol Lett 109:113-119
62. Ignarro LJ (2009) Nitric oxide: biology and pathobiology, 2nd edn. Elsevier Science, New York
63. Zhi H, Yang L, Kuo YL, Ho YK, Shih HM, Giam CZ (2011) NF-kappaB hyper-activation by HTLV-1 tax induces cellular senescence, but can be alleviated by the viral anti-sense protein HBZ. PLoS Pathog 7:e1002025
64. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646-674
65. Lemoine FJ, Kao SY, Marriott SJ (2000) Suppression of DNA repair by HTLV type 1 Tax correlates with Tax trans-activation of proliferating cell nuclear antigen gene expression. AIDS Res Hum Retroviruses 16:1623-1627
66. Yoshida M, Suzuki T (2000) HTLV type 1 Tax oncoprotein binds to DNA topoisomerase I and inhibits its catalytic activity. AIDS Res Hum Retroviruses 16:1639-1645
67. Brown M, Bellon M, Nicot C (2007) Emodin and DHA potently increase arsenic trioxide interferon-alpha-induced cell death of HTLV-I-transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1. Blood 109:1653-1659
68. Dayaram T, Lemoine FJ, Donehower LA, Marriott SJ (2013) Activation of WIP1 phosphatase by HTLV-1 Tax mitigates the cellular response to DNA damage. PLoS One 8:e55989
69. Wiederschain D, Wee S, Chen L, Loo A, Yang G, Huang A et al (2009) Single-vector inducible lentiviral RNAi system for oncology target validation. Cell Cycle 8:498-504
70. Ramadan E, Ward M, Guo X, Durkin SS, Sawyer A, Vilela M et al (2008) Physical and in silico approaches identify DNA-PK in a Tax DNA-damage response interactome. Retrovirology 5:92
71. Smith MR, Greene WC (1990) Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Develop 4:1875-1885
72. Ross TM, Minella AC, Fang ZY, Pettiford SM, Green PL (1997) Mutational analysis of human T-cell leukemia virus type 2 Tax. J Virol 71:8912-8917
73. Moss BL, Gross S, Gammon ST, Vinjamoori A, Piwnica-Worms D (2008) Identification of a ligand-induced transient refractory period in nuclear factor-kappaB signaling. J Biol Chem 283:8687-8698